ETF Managers Group’s Novavax NVAX Stock Holding History

ETF Managers Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$198K	Buy	28,610 +9,038	+46%	+$83.2K	0.01%	585
2022 Q4	$201K	Sell	19,572 -107,677	-85%	-$1.9M	0.01%	479
2022 Q3	$2.32M	Buy	127,249 +109,153	+603%	+$4.73M	0.07%	144
2022 Q2	$938K	Buy	18,096 +1,729	+11%	+$89.6K	0.03%	240
2022 Q1	$1.22M	Buy	16,367 +3,241	+25%	+$289K	0.02%	256
2021 Q4	$2.03M	Sell	13,126 -3,178	-19%	-$546K	0.04%	210
2021 Q3	$3.32M	Sell	16,304 -4,535	-22%	-$999K	0.06%	168
2021 Q2	$4.35M	Buy	20,839 +6,055	+41%	+$1.11M	0.07%	153
2021 Q1	$2.56M	Sell	14,784 -5,883	-28%	-$1.17M	0.05%	168
2020 Q4	$2.46M	Sell	20,667 -11,403	-36%	-$1.21M	0.05%	181
2020 Q3	$3.46M	Buy	32,070 +12,503	+64%	+$1.52M	0.11%	122
2020 Q2	$1.64M	Buy	+19,567	New	+$748K	0.06%	151

Other funds holding NVAX

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ETF Managers Group's NVAX Position: Q1 2023 in Review

ETF Managers Group increased its Novavax (NVAX) stake by 46% in Q1 2023, buying an estimated $83.2K and bringing the position to 28,610 shares worth $198K. The position accounts for 0.01% of the portfolio, ranked #585.

ETF Managers Group first reported a position in NVAX in Q2 2020 and has held it in 12 quarters since. The position peaked at $4.35M in Q2 2021. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

ETF Managers Group held 28,610 shares of Novavax worth $198K as of Q1 2023.
ETF Managers Group bought 9,038 Novavax shares in Q1 2023, an estimated $83.2K.
Novavax made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #585 holding.
ETF Managers Group first reported a position in Novavax in Q2 2020 and has held it in 12 quarters since.
ETF Managers Group's Novavax position peaked at $4.35M in Q2 2021.
222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.